Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Infectious disease / Mycobacteria

Derm Cases · Dermatology / Infectious disease / Mycobacteria

OSCE — apple-jelly nodules and neck sinuses: classify and treat cutaneous tuberculosis

An 8-minute OSCE station on classifying cutaneous TB (lupus vulgaris, scrofuloderma, warty TB, tuberculids), diagnostic biopsy/AFB/PCR pathway, standard RIPE therapy, and distinguishing tuberculids (sterile skin) from true infection.

8 minosce2 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on classifying cutaneous TB (lupus vulgaris, scrofuloderma, warty TB, tuberculids), diagnostic biopsy/AFB/PCR pathway, standard RIPE therapy, and distinguishing tuberculids (sterile skin) from true infection.

Brief (to candidate)

A 40-year-old man from an endemic area has a chronic facial plaque with soft apple-jelly nodules on diascopy. A second patient has a broken-down cervical lymph node with draining sinuses. You have 8 minutes to classify cutaneous TB forms, plan investigations, start ATT, and explain tuberculids.

Candidate instructions

  1. Name major clinicopathologic forms: lupus vulgaris, scrofuloderma, TB verrucosa cutis, orificial/miliary, tuberculids.
  2. Link route of infection (exogenous / contiguous / haematogenous / hypersensitivity).
  3. Plan biopsy + AFB/culture/PCR and systemic TB work-up.
  4. Prescribe standard RIPE anti-TB therapy framework (6 months typical).
  5. Explain that tuberculids are sterile hypersensitivity reactions requiring treatment of the focus.
[9]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
Lupus vulgarisChronic facial plaque; apple-jelly nodules on diascopy; paucibacillary; long-term SCC (Marjolin) risk in chronic plaques — biopsy change[1][2][5]
ScrofulodermaContiguous breakdown of tuberculous node/bone to skin via sinus tracts (often cervical); common cutaneous form in endemic settings[1][2]
Other formsTB verrucosa cutis (warty, exogenous reinoculation in sensitised host); orificial TB (advanced internal disease); miliary cutaneous TB in immunocompromised = emergency; tuberculids (papulonecrotic, erythema induratum, lichen scrofulosorum)[1][8]
Work-upEdge biopsy for granulomas (± caseation); AFB stain/culture/PCR; chest imaging and sputum as indicated; notify per public-health rules[1][5]
TreatmentStandard RIPE (rifampicin, isoniazid, pyrazinamide, ethambutol) ~6 months (extend selected complex cases); surgery adjunct for sinuses after medical control[5]
TuberculidsHypersensitivity to distant TB antigens; skin often culture-negative/sterile — still treat underlying TB focus with ATT, not topical steroids alone as definitive care[8]
CommunicationCounsel adherence, hepatotoxicity monitoring concepts, and scarring/reconstruction timing after quiescence

Model key actions

  • Diagnose lupus vulgaris and scrofuloderma phenotypes and start ATT pathway.[1][5]
  • Biopsy and mycobacterial work-up before or alongside treatment in non-emergency settings.[1]
  • Recognise tuberculids as sterile reactive patterns needing systemic TB control.[8]

Common errors

  • Treating chronic facial plaque as sarcoid/LE without mycobacterial consideration in endemic settings.
  • Antibiotics alone for scrofuloderma without ATT.
  • Assuming tuberculids need only topical therapy because AFB-negative.
  • Missing Marjolin SCC risk in long-standing lupus vulgaris.
  • Confusing paediatric scrofula from NTM adenitis (culture/PCR distinction; management may differ).
[1] [2] [5] [8]
References5ShowHide
  1. [1]Kaul S, Kaur I, Mehta S, et al. Cutaneous tuberculosis. Part I: Pathogenesis, classification, and clinical features. Journal of the American Academy of Dermatology, 2023.PMID 35149149
  2. [2]Chen Q, Chen W, Hao F. Cutaneous tuberculosis: A great imitator. Clinics in Dermatology, 2019.PMID 31178102
  3. [5]Hill MK, Sanders CV. Cutaneous Tuberculosis. Microbiology Spectrum, 2017.PMID 28233513
  4. [8]Dhattarwal N, Ramesh V. Tuberculids: A Narrative Review. Indian Dermatology Online Journal, 2023.PMID 37266079
  5. [9]Gaitonde S, Pathan E, Sule A, et al. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment Ann Rheum Dis, 2002.PMID 11830432
PreviousOSCE — lower-limb cellulitis vs erysipelas and necrotising red flagsDermatology / Infectious Diseases / Emergency MedicineNextOSCE — ash-leaf macules and angiofibromas: TSC criteria, vigabatrin, mTOR inhibitorsDermatology / Paediatrics / Neurocutaneous